XML 88 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Instruments Level 3 (Tables)
12 Months Ended
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments [Table Text Block]
GMWB Hedging Instruments
 
Successor Company
 
Notional Amount
 
Fair Value
 
December 31, 2019
December 31, 2018
 
December 31, 2019
December 31, 2018
Customized swaps
$
3,938

$
3,877

 
$
34

$
71

Equity swaps, options, and futures
855

776

 
(2
)
(25
)
Interest rate swaps and futures
2,189

3,140

 
41

25

Total
$
6,982

$
7,793

 
$
73

$
71

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Successor Company
 
Net Derivatives
 
Asset Derivatives
 
Liability Derivatives
 
Notional Amount
 
Fair Value
 
Fair Value
 
Fair Value
Hedge Designation/ Derivative Type
Dec 31, 2019
Dec 31, 2018
 
Dec 31, 2019
 
Dec 31, 2018
 
Dec 31, 2019
Dec 31, 2018
 
Dec 31, 2019
Dec 31, 2018
Cash flow hedges
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency swaps
$
10

$

 
$

 
$

 
$

$

 
$

$

Total cash flow hedges
10


 

 

 


 


Non-qualifying strategies
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate contracts
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps and futures
3,082

3,152

 
(39
)
 
(101
)
 
11

38

 
(50
)
(139
)
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency swaps and forwards
225

225

 
(7
)
 
(9
)
 
9

7

 
(16
)
(16
)
Fixed payout annuity hedge

270

 

 
(82
)
 


 

(82
)
Credit contracts
 
 
 
 
 
 
 
 
 
 
 
 
Credit derivatives that purchase credit protection
40

45

 
(1
)
 
(1
)
 


 
(1
)
(1
)
Credit derivatives that assume credit risk [1]

372

 

 
3

 

3

 


Credit derivatives in offsetting positions

43

 

 

 

5

 

(5
)
Equity contracts
 
 
 
 
 
 
 
 
 
 
 
 
Equity index swaps and options
2,000


 

 

 


 


Variable annuity hedge program
 
 
 
 
 
 
 
 
 
 
 
 
GMWB product derivatives [2]
8,717

9,957

 
5

 
(80
)
 
23


 
(18
)
(80
)
GMWB reinsurance contracts
1,869

2,115

 
17

 
40

 
17

40

 


GMWB hedging instruments
6,982

7,793

 
73

 
71

 
89

114

 
(16
)
(43
)
Macro hedge program
19,879

10,765

 
(114
)
 
247

 
98

288

 
(212
)
(41
)
Other
 
 
 
 
 
 
 
 
 
 
 
 
Modified coinsurance reinsurance contracts
819

798

 
(43
)
 
12

 

12

 
(43
)

Total non-qualifying strategies
43,613

35,535

 
(109
)
 
100

 
247

507

 
(356
)
(407
)
Total cash flow hedges and non-qualifying strategies
$
43,623

$
35,535

 
$
(109
)
 
$
100

 
$
247

$
507

 
$
(356
)
$
(407
)
Balance Sheet Location
 
 
 
 
 
 
 
 
 
 
 
 
Fixed maturities, available-for-sale
$
43

$
41

 
$

 
$

 
$

$

 
$

$

Other investments
5,779

11,000

 
72

 
212

 
83

248

 
(11
)
(36
)
Other liabilities
26,396

11,623

 
(160
)
 
(84
)
 
124

207

 
(284
)
(291
)
Reinsurance recoverables
2,688

2,914

 
(26
)
 
52

 
17

52

 
(43
)

Other policyholder funds and benefits payable
8,717

9,957

 
5

 
(80
)
 
23


 
(18
)
(80
)
Total derivatives
$
43,623

$
35,535

 
$
(109
)
 
$
100

 
$
247

$
507

 
$
(356
)
$
(407
)
[1]
The derivative instruments related to this strategy are held for other investment purposes.
[2]
These derivatives are embedded within liabilities and are not held for risk management purposes.
Offsetting Assets [Table Text Block]
Offsetting Derivative Assets and Liabilities (Successor Company)
 
(i)
(ii)
(iii) = (i) - (ii)
 
(v) = (iii) - (iv)
 
 
 
Net Amounts Presented on the Statement of Financial Position
Collateral Disallowed for Offset on the Statement of Financial Position
 
 
Gross Amounts of Recognized Assets (Liabilities)
Gross Amounts Offset on the Statement of Financial Position
Derivative Assets [1] (Liabilities) [2]
Accrued Interest and Cash Collateral (Received) [3] Pledged [2]
Financial Collateral (Received) Pledged [4]
Net Amount
As of December 31, 2019
 
 
 
 
 
 
Other investments
$
207

$
187

$
72

$
(52
)
$
8

$
12

Other liabilities
(295
)
(91
)
(160
)
(44
)
(204
)

As of December 31, 2018
 
 
 
 
 
 
Other investments
$
455

$
352

$
212

$
(109
)
$
65

$
38

Other liabilities
(327
)
(147
)
(84
)
(96
)
(178
)
(2
)
[1]
Included in other invested assets on the Company's Consolidated Balance Sheets.
[2]
Included in other liabilities on the Company's Consolidated Balance Sheets and is limited to the net derivative receivable associated with each counterparty.
[3]
Included in other investments on the Company's Consolidated Balance Sheets and is limited to the net derivative payable associated with each counterparty.
[4]
Excludes collateral associated with exchange-traded derivative instruments.
Offsetting Liabilities [Table Text Block]
Securities Lending and Repurchase Agreements
 
Successor Company
 
December 31, 2019
December 31, 2018
 
Fair Value
Fair Value
Securities Lending Transactions:
 
 
Gross amount of securities on loan
$

$
277

Gross amount of associated liability for collateral received [1]
$

$
284

 
 
 
Repurchase agreements:
 
 
Gross amount of recognized liabilities for repurchase agreements
$
269

$
186

Gross amount of collateral pledged related to repurchase agreements [2]
$
273

$
190

Gross amount of recognized receivables for reverse repurchase agreements [3]
$
10

$
25

[1]
Cash collateral received is reinvested in fixed maturities, AFS and short term investments which are included on the Consolidated Balance Sheets. Amount includes additional securities collateral received of $0 and $1 which are excluded from the Company's Consolidated Balance Sheets as of December 31, 2019 and 2018 (Successor Company), respectively.
[2]
Collateral pledged is included within fixed maturities, AFS and short-term investments on the Company's Consolidated Balance Sheets.
[3]
Collateral received is included within short-term investments on the Company's Consolidated Balance Sheets.
Offsetting Derivative Assets and Liabilities (Successor Company)
 
(i)
(ii)
(iii) = (i) - (ii)
 
(v) = (iii) - (iv)
 
 
 
Net Amounts Presented on the Statement of Financial Position
Collateral Disallowed for Offset on the Statement of Financial Position
 
 
Gross Amounts of Recognized Assets (Liabilities)
Gross Amounts Offset on the Statement of Financial Position
Derivative Assets [1] (Liabilities) [2]
Accrued Interest and Cash Collateral (Received) [3] Pledged [2]
Financial Collateral (Received) Pledged [4]
Net Amount
As of December 31, 2019
 
 
 
 
 
 
Other investments
$
207

$
187

$
72

$
(52
)
$
8

$
12

Other liabilities
(295
)
(91
)
(160
)
(44
)
(204
)

As of December 31, 2018
 
 
 
 
 
 
Other investments
$
455

$
352

$
212

$
(109
)
$
65

$
38

Other liabilities
(327
)
(147
)
(84
)
(96
)
(178
)
(2
)
[1]
Included in other invested assets on the Company's Consolidated Balance Sheets.
[2]
Included in other liabilities on the Company's Consolidated Balance Sheets and is limited to the net derivative receivable associated with each counterparty.
[3]
Included in other investments on the Company's Consolidated Balance Sheets and is limited to the net derivative payable associated with each counterparty.
[4]
Excludes collateral associated with exchange-traded derivative instruments.
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]
Cash Flow Hedges
For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness.
Derivatives in Cash Flow Hedging Relationships
 
Gain (Loss) Recognized in OCI
 
Successor Company
Predecessor Company
 
For the Year Ended December 31, 2019
June 1, 2018 to December 31, 2018
January 1, 2018 to May 31, 2018
For the Year Ended December 31, 2017
Interest rate swaps
$

$

$
(17
)
$
(13
)
Foreign currency swaps



4

Total
$

$

$
(17
)
$
(9
)
Derivatives in Cash Flow Hedging Relationships (Successor Company)
 
Gain or (Loss) Reclassified from AOCI into Income 
 
For the Year Ended December 31, 2019
June 1, 2018 to December 31, 2018
 
Net Capital
Gain/(Loss)
Net Investment Income
Net Capital
Gain/(Loss)
Net Investment Income
Interest rate swaps




Foreign currency swaps




Total
$

$

$

$

Derivative Instruments, Gain (Loss) [Table Text Block]
Non-qualifying Strategies
For non-qualifying strategies, including embedded derivatives that are required to be bifurcated from their host contracts and accounted for as derivatives, the gain or loss on the derivative is recognized currently in earnings within net realized capital gains (losses).
Non-qualifying Strategies
Gain (Loss) Recognized within Net Realized Capital Gains (Losses)
 
Successor Company
Predecessor Company
 
For the Year Ended December 31, 2019
June 1, 2018 to December 31, 2018
January 1, 2018 to May 31, 2018
For the Year Ended December 31, 2017
Variable annuity hedge program
 
 
 
 
GMWB product derivatives
$
134

$
(25
)
$
82

$
231

GMWB reinsurance contracts
(13
)
1

(25
)
(49
)
GMWB hedging instruments
(68
)
36

(45
)
(134
)
Macro hedge program
(418
)
153

(36
)
(260
)
Total variable annuity hedge program
(365
)
165

(24
)
(212
)
Foreign exchange contracts
 
 
 
 
Foreign currency swaps and forwards

2

(3
)
(9
)
Fixed payout annuity hedge
(4
)
(15
)
10

4

Total foreign exchange contracts
(4
)
(13
)
7

(5
)
Other non-qualifying derivatives
 
 
 
 
Interest rate contracts
 
 
 
 
Interest rate swaps, swaptions, and futures
103

23

(40
)
4

Credit contracts
 
 
 
 
Credit derivatives that purchase credit protection


1

(12
)
Credit derivatives that assume credit risk
7

(1
)
(3
)
18

Equity contracts




Equity index swaps and options
(1
)


3

Other
 
 
 
 
Modified coinsurance reinsurance contracts
(55
)
13

32

(13
)
Total other non-qualifying derivatives
54

35

(10
)

Total [1]
$
(315
)
$
187

$
(27
)
$
(217
)
[1]
Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 2 - Fair Value Measurements of Notes to the Consolidated Financial Statements.
Disclosure of Credit Derivatives [Table Text Block]
 
As of December 31, 2018 (Successor Company)
 
 
 
 
 
Underlying Referenced
Credit Obligation(s) [1]
 
 
 
Credit Derivative Type by Derivative Risk Exposure
Notional Amount [2]
Fair
Value
Weighted
Average
Years to
Maturity
 
Type
Average
Credit
Rating
 
Offsetting Notional Amount [3]
Offsetting Fair Value [3]
Single name credit default swaps
 
 
 
 
 
 
 
 
 
Investment grade risk exposure
$
80

$
1

4 years
 
Corporate Credit/ Foreign Gov.
A
 
$

$

Basket credit default swaps [4]
 
 
 
 
 
 
 
 
 
Investment grade risk exposure
202

1

5 years
 
Corporate Credit
BBB+
 


Below investment grade risk exposure
80

2

5 years
 
Corporate Credit
B+
 


Investment grade risk exposure
12

(1
)
5 years
 
CMBS Credit
A-
 
2


Below investment grade risk exposure
19

(5
)
Less than 1 Year
 
CMBS Credit
B-
 
19

5

Total [5]
$
393

$
(2
)
 
 
 
 
 
$
21

$
5

[1]
The average credit ratings are based on availability and are generally the midpoint of the available ratings among Moody’s, S&P, and Fitch. If no rating is available from a rating agency, then an internally developed rating is used.
[2]
Notional amount is equal to the maximum potential future loss amount. These derivatives are governed by agreements and applicable law which include collateral posting requirements. There is no additional specific collateral related to these contracts or recourse provisions included in the contracts to offset losses.
[3]
The Company has entered into offsetting credit default swaps to terminate certain existing credit default swaps, thereby offsetting the future changes in value of, or losses paid related to, the original swap.
[4]
Comprised of swaps of standard market indices of diversified portfolios of corporate and CMBS issuers referenced through credit default swaps. These swaps are subsequently valued based upon the observable standard market index.
[5]
Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 2 - Fair Value Measurements of Notes to the Consolidated Financial Statements.